AIIMS was established in 1956 to serve as a nucleus for nurturing excellence in all aspects of health care. The dreams of Pandit Nehru and Amrit Kaur and the recommendations of the Bhore Committee converged to create a proposal which found favor with the government of New Zealand. A munificent grant from New Zealand, under the Colombo Plan, made it possible to lay the foundation stone of All India Institute of Medical Sciences (AIIMS) in 1952. It was finally started in 1956, as an autonomous institution, to serve as a nucleus for nurturing excellence in all aspect of health care. The Institute has comprehensive facilities for teaching, research and patient-care. As provided in the Act, AIIMS conducts teaching programs in medical and para-medical courses both at undergraduate and postgraduate levels and awards its own degrees. Teaching and research are conducted in 42 disciplines.
Apollo Hospitals Enterprise Limited is a an Indian hospital chain based in Chennai. It was founded by Dr Prathap C. Reddy in 1983 and offers healthcare services and operates standalone pharmacies. The company’s segments include healthcare, pharmacy and others. The healthcare segment consists of hospitals, hospital-based pharmacies, and projects and consultancy services. Its tertiary care hospitals provide care in over 50 specialties, including cardiac sciences, oncology, neurosciences, critical care, orthopedics, radiology, gastroenterology and transplant. The tertiary care hospitals has over 9,550 beds across approximately 70 locations, over 2,330 pharmacies, approximately 170 primary care and diagnostic clinics, and over 150 telemedicine units across 10 countries. Italso provides project consultancy services, health insurance services, education and training programs, and research facilities. It also operates birthing centers, day surgery centers and dental clinics. It has been awarded National Business Excellence (BE) Star Awards organized by the Confederation of Indian Industry in 2015.
Aravind Eye Care
Aravind Eye Care System, the world’s largest eye care provider, was chosen for the $1.5 million Conrad N. Hilton Humanitarian Prize as an organization that does extraordinary work to alleviate human suffering. Aravind, founded in 1976 by the late Dr. Govindappa Venkataswamy, operates five hospitals in India backed by a network of clinics, manages four others, and has research laboratories, a training center and a manufacturing center. While a typical ophthalmologist might perform 250 to 400 surgeries annually, an Aravind doctor will average 2,000. As only 30 percent of its patients pay for its services, Aravind’s model hinges on volume and efficiency to keep costs down. Over the years, this organization has evolved into a sophisticated system and now serves as a model, for India, and the rest of the world.
Artemis Hospitals, Gurgaon, is a part of Artemis Health Sciences (AHS), a health care venture promoted by Apollo Tyres Group. It is a 300 bedded multi-speciality hospital. The vision of Artemis hospital is to create an integrated world class health care system, fostering, protecting, sustaining and restoring health through best in class medical practices and cutting edge technology developed through an in-depth research carried out by the world’s leading scientific minds. Its mission is to deliver world class patient care services; excel in specialized medical care supported by comprehensive research and education. It aims to be the preferred choice for the world’s leading professionals and scientific minds to develop, apply, evaluate, and share new technology and be an active partner in local community initiatives. Artemis Hospital has begun the process of full accreditation by the Joint Commission International (JCI) and National Accreditation Board for Hospitals (NABH).
Batra Hospital & Medical Research Centre
Batra Hospital & Medical Research Centre was established in 1987 by Ch. Aishi Ram Batra Public Charitable Trust with full range of state-of-the-art diagnostic laboratories and comprehensive rehabilitation facilities. Batra is considered the capital’s first multi-specialty private hospital that aims to bring world-class medical care within the reach of a common man. Eventually, it has progressed bringing in the latest and the most modern medical care in critical and life threatening areas like cancer, cardiac, orthopedics, nephrology and neuro surgery. At present, the hospital offers a tertiary level care in 42 specialties and has assembled the finest medical talent from across the nation. The skills of the medical professionals are enriched with international experience. This is in line with the continuing ethos of the hospital to combine the best medical care with warmth and tenderness which is essential to the healing process. Batra Hospital also provides proper in-campus accommodation facility to its consultants, DNB doctors and nursing staff to make them feel comfortable.
BGS Global Hospitals
BGS Global Hospitals is a 500-bed healthcare centre offering multi-specialty care was founded by Dr. K Ravindranath, a pioneer in surgical gastroenterology and laparoscopic surgery and an internationally acclaimed surgeon.
To give back to the society, the team of BGS Global ensures patient delight through relentless research, continuous learning and quality medical practice.
The group has been offering specialized tertiary care and multiorgan transplantation services since 1998 and has brought the highest quality of technology, skills and ethics to healthcare in Hyderabad.
Global today exhibits excellence across disciplines including cardiac surgery and heart transplantation, nephrology, urology and kidney transplantation. Original research, at its Global Clinical Research Laboratories, is its forte, and in advanced training across the board lies its strong conviction.
BLK Super Speciality Hospital
BLK Super Speciality Hospital is the largest stand-alone private sector hospitals in Delhi and the range of services offered at BLK make the hospital a force to reckon with in the field of super speciality tertiary healthcare. The hospital has a capacity of 700 beds with dedicated 125 critical care beds, 17 modular operation theatres and specialty-specific dedicated OPD blocks. The facility is equipped with the most modern medical diagnostic and therapeutic equipments.
BLK has India’s largest bone marrow transplant centre and is known world over for excellent outcomes. BLK Cancer Centre is one of the few centres in the world which provides comprehensive cancer care with organ specific specialist teams in holistic manner. It offers advanced services for the treatment of heart conditions including minimal access cardiac bypass surgery. The hospital provides a wide spectrum of super speciality services in the field of neurology, neurosurgery, urology, kidney transplant, nephrology, gastroenterology and surgical gastroenterology, liver transplant, orthopedics including spine surgery, joint replacement and sports medicine.
BLK Super Speciality Hospital is accredited by National Accreditation Board for Hospitals and Healthcare.
Christian Medical College and Hospital
Christian Medical College and Hospital, Vellore (CMC) is a private, minority- run educational and research institute that includes a network of primary, secondary and tertiary care hospitals in and around Vellore, Tamil Nadu. The hospital was founded by Dr. Ida Sophia Scudder in 1900. Ida Scudder was the daughter of second-generation medical missionaries from the Dutch Reformed Church in the United States, who served in India. It is one of the most respected medical destinations in India and internationally. It is also one of the top-ranked medical colleges in India. CMC has brought many significant achievements to India, including starting the first College of Nursing in 1946, performing the first reconstructive surgery for leprosy in the world (1948), performing the first successful open heart surgery in India (1961), performing the first kidney transplant in India (1971), performing first bone marrow transplantation (1986) in India and performing the first successful ABO incompatible kidney transplant in India (2009).
Bombay Hospital & Medical Research Centre, Mumbai
One of the top hospitals in Mumbai, Bombay hospital and medical research center is a well known multi-speciality, tertiary care hospital. Spread over 5, 00,000 square feet with four hospital buildings, Bombay hospital is a premier medical center founded in 1950 by RD Birla. Well equipped with 830 beds, 24 operation theaters and over 200 skilled resident doctors, Bombay hospital caters to all specialties of medicine including cardiology, orthopedics, oncology, neurology and many more. What sets this hospital apart is the fact that it houses the RD Birla International Cardiac center that has the country’s largest coronary artery bypass grafting complex that is said to conducts over 1200 surgeries and 4000 angioplasties every year. Apart from that it has a leading neurosurgery and neurology wing that is capable of handling all types of brain tumours and spinal surgeries. Not only does it look after a patient’s medical needs, it also has a library, museum, and training institute for nurses, further education facilities for its doctors and a pharmacy.
Columbia Asia Referral Hospital
Columbia Asia Referral Hospital Yeshwanthpur is a 200-bed facility located at Gateway Center in Yeshwanthpur, in northwest Bangalore. The hospital was opened in 2008 and provides comprehensive tertiary-level services, such as cardiac operations, orthopedics and neuroscience, as well as secondary-level medical care. Columbia Asia specializes in transplants (kidney, liver), interventional cardiology and cardiac surgery, spine and neurosurgery, orthopedic surgery, medical and surgical oncology, bone marrow transplants, cochlear implants and ENT surgeries, neurological treatments like deep brain stimulation for parkinson’s disease, cosmetic surgery, obesity/bariatric surgery and management of high-risk pregnancies, among others. The hospital has international standard infrastructure and follows globally benchmarked standards of medical, nursing and operating protocols making it the preferred healthcare destination for patients from around the world.
Dr. Ram Manohar Lohia Hospital
It was started during pre independence era and was known as Willingdon hospital. Ram Manohar Lohia Hospital is one India’s first hospitals. Post independence the name was changed and its now functions under the control of the Centre It has been pioneers in India’s medical evolution and is one of the most respected hospitals in the country and enjoys a tremendous goodwill among its patients. It is fully funded by the Ministry of Health Family Welfare. Treatment isn’t refused to the emergency patients. This hospital has round the clock emergency services in medicine, surgery, orthopedics and paediatrics, laboratory, X – Ray, CT-Scan, ultrasound, blood bank and ambulances.
It has grown over the years and is currently having about 1216 beds, spread over in 30 acres of land. It caters to the population of New Delhi and Central District, apart from patients from other areas and even from out side Delhi.
Fortis Healthcare Limited
Fortis Healthcare Limited, a leading healthcare consultant in India has assembled the finest talents in medicine, be it the doctors, nurses or technicians, and even management professionals across a wide spectrum. Fortis Healthcare Limited is one of the leading chains of hospitals and a leader in healthcare consultancy in India which is benchmarked to international standards – achieving quality through the relentless adherence to the protocols observed in some of the world’s leading hospitals. The hallmark of Fortis hospitals, distinguishing them from their contemporaries, is the ‘patient-centricity’ that anyone will discern all over: in hospital design, services, programmes and most significantly in the caring approach of the staff. The Fortis Healthcare circle is a fast expandingname in India reaching out to distant communities, welcoming patients from beyond Indian shores. In its continuous effort to be the number one in healthcare consultancy, Fortis has expanded its wings abroad with an aim to provide quality and affordable healthcare ,starting its journey from Mauritius.
HOSMAT Hospital, Bengaluru
Hospital for orthopaedics, sports medicine, arthritis, accident-trauma, Hosmat Arthritis and Joint Replacement Centre, HOSMAT Neuro Centre and HOSMAT Spine Centre is a super major specialty hospital of 350 beds in Bangalore.
It is undergoing an expansion phase to 500 beds, making it the largest specialty hospital of its kind in Asia.
A contemporary and spacious building has been designed and constructed for orthopedic and neuro patients, the latest state-of-the-art equipment in all disciplines of orthopaedics, neuro surgery; neurology, accident, trauma and sports medicine have been installed. Highly qualified and experienced medical consultants are the mainstay of the hospital.
HOSMAT has gained a reputation of being one of the best hospitals in orthopaedics and its subspecialties making it the first orthopedic and joint replacement hospital to get ISO9002 – TUV Certified.
Dr L H Hiranandani Hospital, founded in honour of the legend, Padma Bhushan Dr L H Hiranandani, came into existence in February 2004. The challenge of the early days was enormous, to foster the fledgling hospital into an enduring symbol of healthcare in the country. The team recognized early on, that to make a real and substantial contribution, one had to redefine the standards themselves, instead of doing more of the same. That set the tone of their endeavour and guided them since then. In 2007, the hospital became the first hospital in western India to receive the prestigious NABH Accreditation for Hospitals and Healthcare providers, an honour accorded to only eight hospitals in the country at the time. In 2008, the hospital received ‘The IMC Ramakrishna Bajaj National Quality Award’ for excellence in healthcare. In 2009, the hospital was the proud recipient of the coveted International Asia Pacific Quality Award (The Malcolm Baldridge Award) as it is known outside in the United States.
JIPMER is a premier medical institute of India located in Puducherry. It is supposed to be one of, if not the best, undergraduate medical colleges in India. Jawaharlal Institute of Postgraduate Medical Education and Research originated as École de Médicine de Pondicherry established by the French Government in 1823.The same was converted into Dhanvantari Medical College at the time of de facto transfer of Pondicherry to Government of India. This Medical College was later upgraded into Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER). JIPMER which includes a tertiary care referral hospital is an Institution of National Importance (an autonomous body) under the Ministry of Health and Family Welfare, Government of India.
Indraprastha Apollo Hospitals
Indraprastha Apollo Hospitals, New Delhi is the first hospital in India to be internationally accredited by Joint Commission International (JCI) consecutively for the fourth time. It is a flagship institution of Apollo Hospitals. It is one of the best multi-speciality tertiary acute care hospitals with over 700 beds in India and the most sought after destination in SAARC region for healthcare delivery. A state-of-the art modern facility, in the heart of the capital, it is spread over 15 acres and has a built-up area of over 600,000 square feet. Currently, the hospital has 695 beds with a capacity to expand to 1,000 beds. Right from the infrastructure to the latest medical technology acquisition, Indraprastha Apollo Hospitals has always kept its patients first and strived to deliver not world class but the world’s best care to its patients since its inception in 1996. The institution holds ISO 14001:2004 certification and NABL accredited laboratories. Other titles and recognitions endowed include “Special Commendation’ for the Golden Peacock Environment Management Award 2011, FICCI healthcare excellent award and many more.
Jaslok Hospital & Research Centre
The Jaslok Hospital & Research Centre is one of the oldest tertiary care, multi specialty trust hospitals of the country. In the late 60s, when the establishment of large private hospitals was not common, the institution was conceptualized and endowed to t Mumbai by Seth Lokoomal Chanrai. He came from a family of philanthropists who had businesses in many countries. Jaslok Hospital is situated at Peddar Road which is a main artery of south Mumbai and overlooking the Arabian Sea. The name Jaslok was derived from the names of Seth Lokoomal and his wife Smt. Jasotibai. His vision was implemented and brought to reality largely by his brother-in-law Dada Mathradas Assomull. The hospital was inaugurated on 6th July 1973 by the erstwhile Prime Minister Indira Gandhi. Jaslok Hospital is a private, full fledged multi speciality hospital with 364 beds of which 75 are ICU beds. The number of consultants has increased from the initial 50 to around 265 with 140 fully trained resident doctors.
Kerala Institute of Medical Sciences (KIMS)
Kerala Institute of Medical Sciences (KIMS), Trivandrum, one of Asia’s leading tertiary care hospitals, is a landmark healthcare destination in Kerala initiated by KIMS Healthcare Management Ltd. The 450 bed multi disciplinary super speciality hospital was started with the objective of providing world class healthcare services and specialized medical facilities at affordable costs. At KIMS, their strength is the team of highly qualified, well experienced senior consultants who are ably supported by high caliber nursing professionals and paramedical staff. With the focus on delivering most modern healthcare services, KIMS healthcare professionals are provided with advanced technologies in medicine and management. KIMS has to its credit the unique achievement of National (National Accreditation Board for Hospitals & Healthcare Providers – NABH), and international (Australian Council on Healthcare Standards International – ACHSI) accreditations for its dedicated healthcare of uncompromising quality. They are empanelled with Government and Semi-Government Institutions in India, Republic of Maldives, Sultanate of Oman, Bahrain, UAE, US and UK. KIMS is an empanelled centre for Australian/ Canadian Visa Medicals.
Kokilaben Dhirubhai Ambani Hospital
Kokilaben Dhirubhai Ambani Hospital is a tertiary-care facility in Versova, Mumbai. The hospital is named after the wife of Dhirubhai Ambani, who was the founder of the Reliance group of companies. The 750 bed multi-speciality hospital was launched in early 2008 for employees and doctors who had accepted offers with KDAH, and became operational in the first week of 2009. The project was initiated in 1999 by Dr. Nitu Mandke as a large-scale heart hospital. It had the first three-room intra-operative MRI suite (IMRIS) in South Asia.
The management of Mandke Foundation approached Reliance Group, as Dr. Nitu Mandke’s dream was cut short by fate when he succumbed to a massive heart attack in May 2003; who graciously took over this project and developed it into one of the most modern and multi-specialty tertiary care hospitals; naming the institution as – Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute.
The Hospital and Medical Research Institute was awarded the Best Multispecialty and Best Super Specialty Hospital in a healthcare summit organized by BW Businessworld.
Lilavati Hospital & Research Centre
This hospital was formed by the Lilavati Kirtilal Mehta Medical Trust. It strives to be known as a concerned nonprofit centre of research and education with hospital and outpatient care. A large team of doctors cover many disciplines of medicine and surgery. A free OPD and charitable ward assists the underprivileged. The premier multi-specialty tertiary care hospital of India has been acknowledged globally as centre of medical excellence. The kind of confidence, trust it has developed on strong foundation of the state-of-the-art facilities, best medical expertise, research, education and charitable endeavors; that today it serves patients from all walks of life. Located in the heart of Mumbai, operational since 1997, it boasts of 323 beds with one of the largest Intensive Care Units (ICUs), most advanced 12 operation theaters, more than 300 consultants and manpower of nearly 1,800. Hospital attends to around 300 In-patients and 1,500 Out-patients daily.
Kohinoor Hospital is Asia’s first LEED Platinum Certified hospital equipped with the latest technology, expert healthcare professionals and latest medical equipment. One of the top hospitals in India and recognized among the best hospitals in Mumbai.
Being a super speciality hospital, Kohinoor Hospital provide excellent services in cardiology, critical care, orthopaedics, neuroscience, minimal invasive surgery and other unique disciplines, so diagnosis and treatment can be prompt and precise. Kohinoor hospital goes a long way in spreading and delivering the preventive health checkups to people The hospital has set up multiple centres of excellence in specialized healthcare; like cardiology, neuroscience, orthopaedics, critical care, minimal invasive surgery and other unique disciplines; so diagnosis and treatment can be prompt and precise.
M S Ramaiah Memorial Hospital
M S Ramaiah Memorial Hospital is a 500 bedded multi super specialty hospital catering to various unique health needs of the patients. The hospital has an indomitable team of doctors and experts whose expertise is amplified by an astounding range of cutting-edge equipment and techno-sharp amenities. The hospital uses state-of-the-art devices, constantly upgrading to meet the latest nuances and changes in the technology so that the standard stays world class. Internationally benchmarked techno-savvy and impeccable are the three words which reflect the quintessence of the hospitals’ infrastructural facilities. The staff and facilities work round-the-clock to ensure timely diagnosis of patient’s health problems.
Manipal Hospital, situated on Airport Road, Bangalore is a landmark destination for quality and affordable healthcare. The 600 bed hospital is the first tertiary care multi super specialty referral centre in Karnataka. Manipal Hospitals has a special significance in the overall healthcare industry of India and particularly in South India. Today, it is the country’s third largest healthcare group with a network of 15 hospitals providing comprehensive care that is both curative and preventive in nature for a wide variety of patients not just from India but also from across the globe. The group’s flagship hospital in Bangalore is NABH accredited and ranked amongst the top 10 multispecialty hospitals in India.
It is India’s first hospital to be ISO 9001:2000 certified for clinical, nursing, diagnostics and allied areas. The hospital has been declared winner of the prestigious Golden Peacock National Quality Award 2005 in the service category.
With a team of some of the best doctors in the world, an attentive staff, state-of-the-art equipment, the hospital provides specialized medical services at affordable costs in over 40 specialties.
Max Healthcare state-of-the-art facilities designed in accordance with international norms include 225 critical care beds, 20 operation theatres, 3 cathlabs, 4 MRIs and 4 CTs across an integrated network. Two of the super speciality hospitals located at Saket, New Delhi have been accredited with NABH certification in patient care. Max Super Speciality Hospital (MSSH) is a multi-speciality hospital, owned and operated by Max Healthcare Institute Limited (MHIL). Max Super Speciality Hospital, Saket is designed to provide highest levels of professional expertise and world class care in all major medical disciplines and support specialities. The operation theatres use state-of-the-art technology such as C-arms and blood gas analyzers while the 71-bed multi-speciality ICU is designed to save the lives of critically ill patients.
Narayana Hrudayalaya Ltd is an India-based company engaged in operating a network of hospitals in India. The company has hospitals in southern state of Karnataka and eastern India, as well as in western and central India. Its centers provide care in over 30 specialties, including cardiology and cardiac surgery, cancer care, neurology and neurosurgery, orthopedics, nephrology and urology, and gastroenterology.
It provides an array of procedures, such as bone marrow transplant, cochlear implant, kidney transplant, liver transplant, joint/knee transplant, left ventricle-assisted device (LVAD), valve repairs and the Ross procedure. Its facility in Bangalore has approximately 225 operational beds. It operates around 60 facilities with over 6,600 operational beds.
Mallya Hospital in Bangalore was established in June 1991 and inaugurated by Bhagawan Sri Sathya Sai Baba. This is a NABH accredited hospital and also first multispecialty hospital in the country to receive ISO-9002 certification. Mallya Hospital has grown over the years with substantial increase in bed strength, infrastructure and an assurance of quality patient care with human touch using state-of-the art technology with quality health care under one roof. At present, the hospital is managed by Chaparral Health Services Limited with Dr.D.K.Audikesavulu as the Managing Director and Commodore Indru Wadhwani as the President. Mallya hospital is well known for its clinical skills, friendly ambience and motivated staff; patients who admit here leave with delight and fondle the memorable moments of their stay.
Medanta is one of India’s largest multi-super specialty institutes located in Gurgaon, a bustling town in the National Capital Region. Founded by eminent cardiac surgeon, Dr. Naresh Trehan, the institution has been envisioned with the aim of bringing to India the highest standards of medical care along with clinical research, education and training. Medanta is governed under the guiding principles of providing medical services to patients with care, compassion, commitment. Medanta is a conglomeration of multi-super specialties institutes which are led by exceptional medical practitioners. Spread across 43 acres, the institute includes a research center, medical and nursing school. It has 1250 beds and over 350 critical care beds with 45 operation theatres catering to over 20 specialties. Medanta houses 6 centers of excellence, which will provide medical intelligentsia, cutting-edge technology and state-of-the-art infrastructure with a well-integrated and comprehensive information system. Medanta integrates modern and traditional forms of medicine to provide accessible and affordable healthcare.
Moolchand Hospital, in heart of Delhi, is a Trust Hospital founded in 1958. Moolchand has won innumerable awards and accolades for quality and excellence over the years. It is India’s first JCI and comprehensive NABH accredited hospital. Moolchand provides you access to over 400 internationally trained and globally acclaimed doctors from 50+ specialties. These highly qualified professionals have an impressive track record of handling complex cases and delivering superior clinical outcomes. They perform over 7000+ surgeries on international patients each year. It is equipped with over 350 beds and Presidential/VIP suites. Patients are guaranteed the best in class care and personal attention the medical team is fully dedicated to providing excellent and compassionate care to their customers. Moolchand has been the preferred choice of patients across the globe including many VIP’s including international diplomats and business leaders. Moolchand International Patients Division assists international patients with flight arrangements, airport pickups, translators, meals, accounts and any other administrative requests from patients. They are the only healthcare organization from Asia and the Pacific Rim to receive the International Asia Pacific Quality Award for world class quality performance.
P.D Hinduja National Hospital and Research Center
P.D Hinduja National Hospital and Research Center is a well known muti-speciality, tertiary care hospital based in Mumbai. Founded by the late Parmanand Deepchand Hinduja, the hospital was started as succour for refugees of India’s partition. Initially, set up as a small out patient clinic called ‘Seth Deepchand Gangaram Hinduja Health Care’ in December 1951, Hinduja hospital took a full-fledged step into healthcare a year later when it was handed over to the then newly formed ‘National Health and Education Society’. Subsequently named P. D. Hinduja National Hospital and Medical Research Centre, the once small OPD unit was expanded into a 300 bedded tertiary care hospital housed in a 16 storey building. Following the principle of ‘temple of modern healthcare’, P.D Hinduja hospital was a pioneer in the practice of having full time consultants (where doctors work in a hospital and not in individual clinics) in Mumbai.
The hospital’s state-of-the-art laboratory is now accredited under NABL and NABH. Hazard Analysis & Critical Control Points (HACCP) is considered the apex certification when it comes to quality, safety and hygiene of food.
Rockland Hospital in Qutub Institutional Area, Delhi
The hospital has redefined health care delivery system in India. Rockland Hospital, Delhi, is a multi-specialty hospital that is run by Foundation for Applied Research in Cancer (FARC). The hospital was established to provide quality health services in the society. The logo of the hospital symbolizes its commitment to provide world-class services while maintaining the highest standards of excellence. It has a diligent team of professional as well as highly qualified doctors. Patients living in this hospital can enjoy the breath taking view of Sanjay Van and Qutub Minar from this hospital. The health center has received ISO 9001:2008 certification.
Ruby General Hospital
Ruby General Hospital in Kolkata has a well versed team of medical practitioners, technicians, nurses and other administrative staff. Ruby General Hospital has around 175 renowned senior consultants of different specialties and around 50 in-house doctors who are always available. The hospital has around 40 beds that have been exclusively dedicated for I.C.C.U. and I.T.U. to provide emergency and critical care to the patients. Trauma care cases are treated here with a high success rate. There are around 42 multi-specialty departments under which the treatment is available, like neurology, orthopaedics, cardiology, oncology, dermatology, haematology, gynaecology and obstetrics, neonatal care and paediatrics, ENT, general medicine, general surgery, gastroenterology, nephrology, radiology, dentistry and others.
Ruby Hall Clinic
Ruby Hall Clinic had a humble beginning when the founder chairman, Dr. K.B. Grant, an eminent cardiologist, started a small nursing home in 1959 in the bungalow, Ruby Hall, owned by General David Sassoon with just two beds. In 1966, it was converted from a private institution to a public charitable trust – Poona Medical Foundation. It was later converted to the Grant Medical Foundation in 2000.
Ruby Hall Clinic is one of the largest medical institutions of western India with a multi specialty hospital dedicated to the diagnosis, treatment and research related to various diseases. It is a 550-bed hospital with a staff of 300 senior Consultants, 6000 panel doctors and 1600 paramedical staff.
Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS)
Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), in Lucknow, is one among the best medical institutes of the country, having been set up in 1983 and was christened after Sanjay Gandhi. It is an institute that is found over an area of 550 acres, with a residential complex on the road to Raebareli at a distance from main city about 15 kms. Many degrees in post graduation are provided by the institute in a variety of subjects under the recognition by the Medical Council of India. The hospital works as a referral hospital and patients are required to bring a referral slip from the referring physician.
Sankara Nethralaya (SN)
Sankara Nethralaya (SN) is a not-for-profit missionary institution for ophthalmic care (i.e., an eye hospital) in Chennai. In “Sankara Nethralaya” Sankara is a reference to Adi Shankaracharya and Nethralaya means “The Temple of the Eye”. Sankara Nethralaya receives patients from India and internationally. Nani A. Palkivala, former Indian ambassador to United States, described Sankara Nethralaya as the “Best managed charitable organization in India”. Sankara Nethralaya has 1,000 employees and serves 1,200 patients per day, performing 100 surgeries per day. It is the first ISO 9002 certified eye hospital in Asia. The main hospital enjoys NABH accreditation, the highest recognition in the health care sector.
Seven Hills Hospital, Mumbai
The city of Mumbai has many good hospitals and this hospital is one among the best. Sevenhills Healthcare Limited is part of the SevenHills Group which has for the last 20 years offering invaluable services in the healthcare sector. The group has 2 hospitals one at Andheri east, Mumbai, and the other one at Visakhapatnam in Andhra Pradesh. The hospitals of this healthcare group offer the best medical services to over 50 million Indians. The hospital is AHA Certified and is compliant with international accredited hospital architectural norms. There are 120 OPD chambers on one level for the convenience of the patients. It is one of the few hospitals in the world to have a huge inpatient bed capacity of 1500. There are 24 dialysis units, 36 operation theatres and 4 cath labs. It has some of the best and latest medical technological equipments. The hospital was awarded the Best Hospital for International Medical Tourism, 2012 and Best ICT Enabled Hospital Award, 2011.
Sir Ganga Ram Hospital
The hospital was founded initially in 1921 at Lahore by Sir Ganga Ram, a civil engineer and leading philanthropist of his times. After the partition in 1947, the present hospital was established in New Delhi on a plot of land approximately11 acres. The foundation was laid in April 1951 by the then Prime Minister of India Shri Jawahar Lal Nehru and inaugurated by him on 13 April 1954. It is a 675-Beded multi-speciality state-of-the-art hospital in India. It provides comprehensive healthcare India services, and has acquired the status of a premier medical institution. It is the only hospital in the private sector that has maintained nearly 100% bed occupancy due to its reputation of providing the highest level of medical services to patients from Delhi and neighboring states.
Sri Ramachandra Medical Centre (SRMC)
Sri Ramachandra Medical Centre (SRMC) is a quaternary care multi-specialty hospital. It was founded by Late NPV Ramasway Udayar in 1985. Today, SRMC is a leader in health care delivery in south India providing cutting edge state-of-art care for patients who walk through its portals daily.
The Medical Centre is located in a sprawling 175-acre campus that is lush green throughout the year. Ramachandra has the best physicians, surgeons and health care providers across all medical and surgical specialities and sub specialities.
First and only hospital affiliated to a medical university in India that has the privilege of JCI, NABH, NABL and AABB accreditations. This highlights the quest for quality health care delivery and continuous quality improvement.
The Breach Candy Hospital
The Breach Candy Hospital has been designed by an English architect Claude Batley. Established in 1950, this hospital is at an upmarket area in the same name (Breach Candy) in south Mumbai. It is a 212 bed hospital and well equipped with modern diagnostic equipment.
Breach Candy Hospital Trust is a multi-speciality, tertiary care, private hospital that has been serving the healthcare needs of people for over 50 years. It is renowned for its medical expertise, excellent nursing staff and quality diagnostic capabilities. The hospital has a number of world renowned doctors in its panel and is known to be the first hospital to perform — now routine procedures — like a coronary angioplasty and hysteroscopy.
It was also the first hospital to have services like Magnetic Resonance Imaging (MRI) and a Critical Care ICU. The hospital aims at providing stat-of-the-art healthcare while being compassionate towards their patients. They house over 200 specialists and cater to all medical needs a patient might have; with an array of specialities like cardiology, orthopaedics, pediatrics etc. the hospital is a haven for the ill.
The Madras Institute of Orthopedics and Traumatology (MIOT)
The Madras Institute of Orthopedics and Traumatology (MIOT) is a multi-specialty hospital located in the Manapakkam area of Chennai. It is a specialized hospital in the field of joint replacement surgeries, orthopedics and trauma. MIOT offers specialized treatment for nephrology, thoracic and cardiovascular care, neurology, pediatric cardio surgery, and gastroenterology.
The hospital founded by Dr. P.V.A. Mohandas which was started as a hospital exclusively for orthopedics and trauma later developed into a premier multi-specialty hospital. The institute not only attracts patients from India and the neighboring countries of Sri Lanka, Bangladesh, Nepal, Pakistan, and Singapore but also from Africa and the Middle East.
MIOT is a pioneering centre for joint replacement surgery in India with phenomenal success rate. It is the first hospital in the Asia-Pacific Region and the second in the world to have Computer Integrated Navigation System for joint replacement surgery. It is one of the most preferred places for Revision Surgery for joint replacements in the country.
The King Edward Memorial (KEM) Hospital
The Seth Gordhandas Sunderdas Medical College (GSMC) and the King Edward Memorial (KEM) Hospital, which was founded in 1926 it is one of the oldest and one of the best teaching and medical schools in Mumbai. The medical college offers training to students in undergraduate, postgraduate, and super specialty medical courses in various allied specialties. The King Edward Memorial Hospital is reputed for its patient healthcare services. It has a team of physicians, resident doctors, and para-medical staff who manage all the departments and services at the hospital efficiently. The Municipal Corporation of greater Mumbai funds the hospital, and therefore, the services at the hospital are virtually free for the benefit of the underprivileged sections of the society. The King Edward Memorial (KEM) Hospital has an excellent neurology department that offers all the ultra modern facilities. The Department of Chest Medicine offers excellent facilities for diagnosis, investigation, and treatment of various disorders of the chest. The Department of Orthopedics at the KEM Hospital caters to about 400 patients every day and has a bed-strength of 280.
Tata Memorial Hospital
Tata Memorial Hospital was an initiative by the Tata group of companies in 1941 in Parel, Mumbai. It is also India’s premier centre for cancer research in the country. It is one of the first and the best cancer research hospitals in the country. They have started the preventive oncology which plays a very big role in the early stages, the diagnosis of cancer and down staging it. This hospital also has a dental department, general medicine category and dispensary and pathology. Even digestive diseases treatment is also made available and they have some of the best physicians and surgeons visiting their hospital to treat patients, hence considered to be one of the best hospitals concerning general medicine.
The Postgraduate Institute of Medical Education and Research
The Postgraduate Institute of Medical Education and Research (or PGIMER) is a medical and research institution located in Chandigarh, India. It has educational, medical research and training facilities for its students. The founders of the institute are Tulsi Das, Santokh Singh Anand, P N Chuttani, B N Aikat, Sant Ram Dhall and Bala Krishna. PGIMER was conceived and planned in 1960 to provide physical and intellectual environment for young scientists working in multiple disciplines of medicine, to advance the frontiers of knowledge to render humane service to sick and suffering and to train medical and paramedical manpower, in Chandigarh. The Institute was established in 1962 under the erstwhile state of Punjab. It was declared as an Institute of National Importance by an Act of Parliament (Sr. No. 51 of 1966) w.e.f. 1 April 1967.
The National Institute of Mental Health and Neuro Sciences (NIMHANS)
NIMHANS is a multidisciplinary institute for patient care and academic pursuit in the field of mental health and neurosciences. It provides high standards of clinical care, quality training and cutting-edge research in the frontier areas. A special feature of this institute since its inception is the combination of research and training with preventive and curative aspects of clinical services. NIMHANS has made significant progress and is a centre for excellence in mental health and neuroscience in the country. The Central Government recognized its eminent academic position, growth and contributions, and declared it a ‘Deemed University’ in 1994. In 2012, NIMHANS was conferred the status of an ‘Institute of National Importance’.
The hospital is a sub-unit of Vijaya Group of Hospitals providing best healthcare services to its patients. It is a multi-specialty hospital with more than 750 beds. The hospital was founded by Shri. B. Nagi Reddy with an aim to cater healthcare services to both Indian as well as international patients. The hospital was established in 1972. The hospital has excellent infrastructure and consists of modern facilities for doctors as well as patients. It consists of educated and trained staff members who take care of each and every patient’s health and treat them as quickly as possible. All the wards are hygienically maintained. They are designed to create pleasant and homely atmosphere for patients. Patients are treated like a family member and assisted with care.
Wockhardt Hospitals, has become first super speciality hospital in South Asia to achieve accreditation from Joint Commission International (JCI), USA.
Wockhardt has associated with Harvard Medical International, USA, to bring you Wockhardt Hospitals, Mumbai. It joined hands with the Government of Maharashtra to set up a 250 – bedded super-specialty hospital in Mumbai, with state-of-the-art surgical and medicare facilities. With latest technology, multi-disciplinary capability, state of the art facilities, world class infrastructure and excellent patient care ambience and processes, Wockhardt Hospitals is poised to become the most advanced and progressive healthcare institution in India. Wockhardt will hold 51 percent of the joint venture equity and the Government of Maharashtra with the funding assistance of the World Bank will hold 49 percent.
Aarti Industries Limited
Aarti Industries Limited is a manufacturer of specialty chemicals and pharmaceuticals. Aarti started its operations in1975 as alchemie labs. The company also manufactures home and personal care products. It operates through three segments: speciality chemicals, pharmaceuticals and home and personal care chemicals. Aarti is one of the leading suppliers to global manufacturers of dyes, pigments, agrochemicals, pharmaceuticals and rubber chemicals and has acquired world-class expertise in the field. It is amongst the largest producers of benzene based basic and intermediate chemicals in India. It has corporate office in Mumbai and representatives in U.S.A and Europe. The company is integrated across over 70 products.
Abbott India Limited
Abbott, incorporated in 1910, is engaged in the discovery, development, manufacture and sale of a line of healthcare products. Abbott has a diverse range of science- based nutritional products, diagnostic tools, branded generic pharmaceuticals, and vision, diabetes and vascular devices.Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories, takes pride in offering high-quality trusted medicines in multiple therapeutic categories such as women’s health, gastroenterology, cardiology, metabolic disorders and primary care. Abbott India Limited is part of Abbott’s global pharmaceutical business in India and one of the fastest-growing pharmaceutical companies. Abbott India Limited believes in providing quality healthcare through a mix of global and local products for people in India.
Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited manufactures and sales enzymes for India and abroad. It provides solutions to industries, such as human healthcare and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, natural extraction, textile processing, leather processing, paper and pulp processing, biofuels, biomass processing and biocatalysts. Company aims to replace traditionally used chemicals with eco-friendly enzymatic solutions. It has pioneered in the production of enzymes in India and continues to set trends with the research & development of new applications for the use of enzymes across various industries. Equipped with state-of-the-art manufacturing facilities and research and development centers across India and US, the company offers several 100 enzyme products.
Ajanta Pharma Limited
Ajanta Pharma Limited is a holding company. It is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations. Its business includes branded generics in emerging markets such as Asia and Africa and developed markets such as the United States and institutional sales. The branded generics business is spread in India and over 30 emerging countries across Africa, commonwealth of independent states (CIS), the Middle East and South East Asia. The company serves a range of therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory and general health products. It has approximately four existing manufacturing plants located in and around Aurangabad in Maharashtra.
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and intermediates. It is engaged developing formulations and active pharmaceutical ingredients (API). The company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The company offers international and domestic formulations.
Alkem Laboratories Limited
Alkem Laboratories Limited is a pharmaceutical company established in 1973. The company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The company operates through two segments: pharmaceutical and investing. It produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. It is currently ranked the fifth largest pharmaceutical company in India in terms of domestic sales for the fiscal year 2016 with its iconic brands like Clavam, Pan, Pan-D, Taxim and Taxim-O featuring amongst the top 50 pharmaceutical brands in India. The company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States. The company is listed on BSE and NSE.
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited is a global biopharmaceutical company. It was established in 1979 and is headquartered at Bengaluru. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular and metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. It operates through two segments: healthcare and clinical trial. The healthcare segment engages in the manufacture and sale of pharmaceutical products. The clinical trial segment renders services on pharmaceutical products to its group companies. It has presence in over seven areas of healthcare, including diabetes, oncology, infection, local anesthesia and maternal healthcare. The principal products/services of the company are Meronem and Brilinta/Axcer.
Astec LifeSciences Limited
Astec LifeSciences Limited is an India-based holding company incorporated in 1994. The company is engaged in agro chemicals, including fungicides and herbicides business. It manufactures a range of agrochemical active ingredients and pharmaceutical intermediates. Astec manufactures a wide range of agrochemical active ingredients and pharmaceutical intermediates. Astec’s considerable experience in the development and production of intermediates and active ingredients makes it an ideal partner. Astec has stable relationships with large and small companies all over the world. Astec has an unshakeable reputation for providing quality products in manufacturing plants that meet global standards. In addition, the company has undertaken a number of custom synthesis projects for customers in Europe, Japan and the United States.
Arvind Remedies Limited
Arvind Remedies Limited is an India-based company engaged in manufacturing pharmaceutical products. It is focusing on chronic diseases segments like diabetics, arthiritis and obesity.
The company has presence in both retail, as well as institutional segments. It sells its products India and other countries. The company’s subsidiaries include Arvind Wellness Limited, Arvind Remedies Inc. and Arvind Remedies USA LLC.
Aurobindo Pharma Limited
Aurobindo Pharma Limited is a pharmaceutical company thatproduces oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It also develops inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.
Biocon Limited is a biopharmaceutical company that focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The company has developed and taken a range of novel biologics, biosimilars, differentiated small molecules and affordable recombinant human Insulin and analogs from lab to market. The company’s brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of biosimilars and novel biologics at various stages of development, including insulin tregopil, an oral insulin analog.
Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad. Over the last six decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over eighty-five other countries around the world. The company is present in more than forty-five therapeutic areas focusing strongly on innovation and research, spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals. Cadila Pharmaceuticals Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations manufacturing plant at Dholka near Ahmedabad, is spread over hundred acres of land. This state-of-the- art facility is not only impressive in size, but is also USFDA approved.
Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is a pharmaceutical company. The company’s product segments include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmics, pain management and anti-ulcers. It offers a range of products, including tablets, liquid orals, capsule, softgel capsules, suppositories and ovules, powder for injection, dry syrup, topicals, liquid injections, inhalers, intravenous (IV) infusion, lyophilized products, branded products, dermo cosmetics and other products. It also manufactures a range of ointments, creams, gels and lotions. Caplin Point has made a foray into the regulated markets with its latest manufacturing facility that is already approved by EU-GMP and ANVISA-Brazil. The facility is awaiting the coveted US FDA approval for injectables in the near future.
Cipla Limited is a global pharmaceutical company incorporated in 1935. The company’s strategic business units include active pharmaceutical ingredients (APIs), respiratory and Cipla Global Access. Its geographical segments include India, USA, South Africa and rest of the world. The company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The company offers its products for the therapeutic areas, including cardiovascular, children’s health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women’s health.
Claris LifeSciences Limited
Claris LifeSciences Limited is a holding company. The company manufactures drugs and pharmaceutical products for India and abroad. Its subsidiary, Claris Injectables Limited, is engaged in specialty injectables business. The company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective’s, critical care, and nephrology. The company, through Claris Otsuka Private Limited, is engaged in infusion products business across therapeutic segments, including infusion therapy, parenteral nutrition and plasma volume expanders. Its products are offered through various delivery systems, such as glass and plastic bottles, ampoules and bags. It provides its services to government and semi-government institutions, group corporate hospitals and nursing homes.
Dishman Pharmaceuticals and Chemicals Limited
Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries. Its segments include contract research and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats, specialty chemicals and traded goods. The company’s CRAMS business segment caters to the requirements of multinational pharmaceutical companies across the world. Its product portfolio includes active pharmaceutical ingredients (APIs), high potent APIs, intermediates, phase transfer catalysts, Vitamin D, Vitamin D analogues, cholesterol, lanolin-related products, and antiseptic and disinfectant formulations. Its products are used in various applications, such as phase transfer catalysts, fine chemicals and disinfectants. Its business units include generic API, dishman specialty chemicals, and dishman care.
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The company was founded by scientist, philanthropist and entrepreneur, Dr. K Anji Reddy. The company operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI), and proprietary products. The global generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company’s business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is engaged in providing diagnostic and related healthcare tests and services. The company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno- chemistry, immunology, virology, and cytology, other pathological and radiological investigations. The company’s geographical segments include India and abroad. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of liver, disorders of bone, drugs of abuse, infertility, lymphoma, water purity, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, pregnancy and viral infections. The company’s other offerings include diabetes care program, loyalty card and wellness card.
Divi’s Laboratories Limited
Divi’s Laboratories Limited established in1990 manufactures and sale of active pharmaceutical ingredients (APIs) and intermediates. The company’s geographical segments include India (sales to customers within India) and other countries (sales to customers outside India). Its products include generic APIs, intermediates, peptide building blocks and carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The company develops carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin and canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in Andhra Pradesh and Telangana in India.
Elder Pharmaceuticals Limited
Elder Pharmaceuticals Limited manufactures and markets prescription pharmaceutical brands, surgical and medical devices. The company operates through Pharmaceuticals segment. It has operations in therapeutic segments, such as women’s health, wound care, pain management, anti-infective, nutraceuticals and lifestyle disease care. The company’s products under active pharmaceutical ingredients (API) list include Diosmin, Diacerein and Tolfenamic Acid. Its formulation products include products for hormones, calcium supplements, dietary products, anti-hemorrhoidal products and wound care products. It also offers hair care products, such as hair conditioner and hair cream; skin care products, such as facial scrub, face wash; soaps, such as acne soap and moisturizing soap, and ayurvedic products, such as Paynx balm.
Fresenius Kabi Oncology Limited
Fresenius Kabi Oncology Limited is a public company operating in the field of research and development and manufacturing of world-class oncology drugs. The company strives to provide state-of-the-art third generation chemotherapeutic drugs right from development to manufacturing and marketing across the globe. It is fast budding as a leading player in oncology generics on the strength of its comprehensive product portfolio of injectables, oral cytotoxics, cytostatics, intermediates and active pharmaceutical ingredients (APIs). The company develops, manufactures and markets anti-cancer products for critically and chronically ill patients. As a part of the globally reputed Fresenius Healthcare Group, it plays a pivotal role in patient care, both within and outside hospitals. The company has been able to leverage the global outreach in benchmarking oncology excellence with latest world class production, ultramodern manufacturing and research and development facilities.
FDC Limited is a pharmaceutical company that manufactures specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. FDC carries forward the flaming spirit of its first dream, achieving accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the UAE, to cite a few. FDC has also set-up globally approved, multi-location manufacturing facilities for active pharmaceuticals ingredients (APIs) as well as finished dosage forms. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.
Eli Lilly and Company Ltd
Eli Lilly and Company Ltd was incorporated by Colonel Eli Lilly in 1876. It is the 10th largest pharmaceutical company in the world at present. Lilly has remained committed to creating medicines that help improve peoples’ quality of life. Eli Lilly & Company has discovered, developed and acquired innovative new medicines that address key unmet medical needs worldwide for more than 140 years. Across the globe, company also has strong alliances and partnerships that advance its capacity to develop innovative medicines at lower costs. Eli Lilly and Company India Pvt. Ltd. is the wholly-owned Indian subsidiary of Eli Lilly and Company. Since its inception in India, in 1993, Lilly has been committed to developing and marketing pharmaceutical products to treat diabetes, cancer, osteoporosis and growth-hormone deficiency.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The company’s product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company’s manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore. GSK has ranked as the No.1 Most Reputed Pharmaceutical brand amongst MNC’s in India.
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited is a global pharmaceutical company established in 1977 by Emeritus Late Mr. Gracias Saldanha. The company develops new chemical entities (NCEs) and new biological entities (NBEs). It supplies are India, United States, Latin America, Europe and rest of the world. It has approximately seven molecules, over two NCEs and approximately five NBEs in various stages of pre-clinical and clinical development. It is focused on developing and marketing branded and generic formulations. It focuses on manufacturing products across therapeutic areas of dermatology, respiratory and oncology. Its active pharmaceuticals ingredients (API) business spans over 80 countries, including regulated markets of the United States, Europe, Japan and Canada. Its products are primarily marketed in the United States and western Europe. It has offices in over 40 countries, and operates approximately 20 manufacturing facilities in over five countries. It operates over five research and development (R&D) centers.
Granules India Limited
Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The company’s business operations include three areas: core business, emerging business, and contract research and manufacturing services (CRAMS). Its products in core business include Paracetamol, Ibuprofen, Guaifenesin and Metformin. The company operates a healthcare division, Granules Consumer Healthcare (GCH). The company, through an acquisition, has access to over 10 APIs, as well as intermediates in therapeutic categories, such as anti-histaminic, antihypertensive and anti-convulsants.
Haffkine Bio-Pharmaceutical Corporation Ltd
Haffkine Institute was founded by Dr. Waldemar Mordecai Haffkine on 10th January 1899. It is located in Parel in Mumbai. In 1975, it was divided into Haffkine BioPharmaceutical Corporation Ltd and Haffkine Institute of Training, Research and testing, focused on vaccine production and research. Recently, it has been short-listed by the Maharashtra government as the future institution for providing clinical trial training to doctors, pharmacologists and scientists across India.
Haffkine BioPharmaceutical Corporation Ltd developed first indigenous oral polio vaccine (OPV). Owing to strategic planning and sustained efforts, the company has been increasing its profits since 1997-98. It had employee strength of about 600 in 2001-02. Its R&D laboratory in Pimpri has been producing antitoxins and sera for scorpion and snake venom, diphtheria and tetanus toxins. It has a well-equipped animal-breeding lab in Mumbai.
Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients (APIs) and contract research activities. Established in 1988, Hikal is a reliable partner to companies in the pharmaceuticals, biotech, agrochemicals and Specialty Chemicals industries. The company’s advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. The company offers pharmaceuticals and agrochemicals. Its segments include crop protection and pharmaceuticals. The company operates in geographical areas, including India, Europe, the United States, Canada and South East Asia.
Indoco Remedies Limited
Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The company primarily manufactures and markets formulations (Finished Dosage Forms) and active pharmaceutical ingredients (APIs). The company’s geographical segments include India andabroad It offers products for various therapeutic categories, such as stomatologicals, respiratory, anti-infectives, gastrointestinal, pain/analgesics, gynecological, vitamins/minerals/nutrients, ophthal/otologicals and dermatology. Its domestic marketing divisions include INDOCO, SPADE, Warren NxGen, Warren Ace, Spera, Indoco Focus, Indoco CND, Warren Excel, Warren Vision, Eterna, Institution and Indoco IMPULSE. As of today, the company operates in over 35 countries globally for Formulations and APIs. With approval of its Finished Dosage facilities by the US – FDA, Darmstadt – Germany, TGA Australia, MCC-South Africa and UK – MHRA, Indoco has emerged as the most suitable partner and provider of Contract Research and Manufacturing Services (CRAMS) to its customers globally.
Kopran Limited’s business units include finished dosage forms, active pharmaceutical ingredients, research and D\development, and consumer healthcare. It offers its products in therapeutic categories, such as anthelmintic, anti-allergic, antibiotic, cardiovascular, diabetic, gastroenterology, pain and antipyretic, and pain management, among others. In addition, it offers oral care, lifestyle, beauty and personalized hygiene products. Its manufacturing facility is located at Khopoli, Maharashtra. The company’s subsidiaries include Kopran Research Laboratories Limited, Kopran (H.K) Limited and Kopran Lifesciences Limited. Kopran’s products are registered globally and its facilities match best of international standards and are approved by various regulatory authorities. It is focused on improvement in technology and new products duly integrated through their sophisticated R&D development.
Lupin Limited produces, develops and markets a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The company offers products in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and non-steroidal anti-inflammatory drug therapy areas. It also offers solutions in the anti-tuberculosis (anti-TB) and cephalosporins therapy areas. The company along with its subsidiaries has manufacturing locations spread across India, Japan, the United States, Mexico and Brazil.
It was named after the Lupin flower because of the inherent qualities of the flower and what it personifies and stands for. Forty six years on, what has stayed with Lupin is that same entrepreneurial spirit, culture of creativity and innovation and pride in belonging to an industry that makes a difference in the lives of people.
Mankind Pharma was incorporated in 1986. In 1991,it was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. The company provides a wide range of products – antibiotic, antifungal, NSAIDs, gastrointestinal, anthelmintic, cardiovascular, dermal, erectile dysfunction, and several other categories – across the nation.
In 2007, Mankind acquired Magnet Labs Pvt Ltd, establishing a marketing presence in the antipsychotic segment. Later in January 2010, the company acquired the former brand of UCB Belgium, Longifene.
Mankind Pharma takes great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, PregaNews, Adiction, Gas-O-Fast, Kaloree 1, and our latest launch, Heal-O-Kind.
Marksans Pharma Limited
Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company’s product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous.The Company undertakes research and development initiatives, and offers customer relationship management (CRM) services to global pharmaceutical companies. The Company has a manufacturing facility for the manufacture of oral solid tablets and soft gelatin capsules in Goa; a liquids/ointments/sachets manufacturing facility in Southport, the United Kingdom, and a solid oral dosages manufacturing facility in New York, the United States. It supplies products to approximately 20 countries. Its subsidiaries include Nova Pharmaceuticals Australasia Pty Ltd. and Marksans Pharma (UK) Limited.
Merck Limited is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. Merck Limited (formerly E. Merck Limited) was set up in India as Merck’s first Asian subsidiary in 1967. It was also the first Merck Group Company to go public in 1981. The company operates through two segments: pharmaceuticals and chemicals. Its geographical segments include domestic and exports.
Merck’s state-of-the-art Galenic and Analytical Development Laboratory in Navi Mumbai enables it to react faster to market demands, have better quality control and ensure world-class formulations by developing in-house various galenic forms like tablets, capsules, injections, syrups, dry powders, creams, etc.
Morepen Laboratories Limited
Morepen Laboratories Limited is a pharmaceutical company. The company’s divisions include active pharmaceutical ingredients (API), home diagnostics and finished formulations. The company offers products under the self-health diagnostic brand home health. Its home health portfolio includes automatic digital blood pressure monitors, digital and analog weighing scales, body and foot massagers, heat therapy range, nebulizers, pregnancy cards, and clinical and digital thermometers. It markets various brands of medical devices and clinical diagnostic products. The company operates in India, the United States and rest of world. Morepen’s state-of-art manufacturing facility in the picturesque environs of Baddi comprises a scientifically integrated complex of 10 plants, each with a specific product profile. The company’s extensive R&D facilities and factories are manned by a dedicated team of professionals who ensure stringent quality standards.
Micro Labs Limited
Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. Energetically backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations. Micro’s brand portfolio includes some of the topmost brands in various specialties like cardiology, diabetology, anti-infectives, ophthalmology, pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management. The company is also at the front position in social contribution, striving to be a model corporate citizen in terms of environmental protection and social initiatives with significant contributions in the areas of education and health.
Natco Pharma Limited
Natco Pharma Limited is a pharmaceutical company incorporated in Hyderabad in 1981 with an initial investment of Rs 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.
The company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company’s segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. Its product categories include Domestic Formulations, International Formulations, API’s and Blockbusters. The company manufactures over 20 products under contract.
Novartis AG, incorporated on March 1, 1996, is a holding company. The Company specializes in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals, including eye care products.
Its portfolio includes medicines, eye care and generic pharmaceuticals. The Company’s segments include Pharmaceuticals which researches, develops, manufactures, distributes and sells prescription medicines in the therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience and established medicines. The history of Novartis traces the converging destinies of three companies: Geigy, a chemicals and dyes trading company founded in Basel, Switzerland in the middle of the 18th century; Ciba, which began producing dyes in 1859; and Sandoz, a chemical company founded in Basel in 1886.
Nicholas Piramal India Limited
The Piramal Group acquired shareholding of F.Hoffmann-La Roche Ltd., Switzerland, in the Indian subsidiary, Roche Products Limited. Post acquisition, the company was renamed as Piramal Healthcare Ltd. Piramal Healthcare Limited was later merged with the group’s flagship pharma company Nicholas Piramal India Ltd. For the past 40 years, Nicholas Piramal India Limited’s vitamin and fine chemicals division has been manufacturing and selling the most important micro-nutrients and vitamin A. The plant at Thane have obtained the coveted ISO 9001 and ISO 14000 certificates and also the SQF 2000 and HACCP Certification and the Pithampur plant obtained ISO 14000 certificate from BVQI, making NPIL one of the first seven pharmaceutical companies in India to do so.
Orchid Pharma Limited
Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is an India-based pharmaceutical company. The company is globally present across 70+ countries through alliances, joint ventures and partnerships with globally reputed majors. The Company is involved in the development, manufacture and marketing of various bulk actives, formulations and nutraceuticals. It offers active pharmaceutical ingredients (API), including Cephalosporins-Orals, Cephalosporins- Injectables, Veterinary Products and Non-Antibodies. Established in 1992 as an export-oriented unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. The company today rank among the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products.
Paras Pharmaceuticals Limited
Paras Pharmaceuticals Limited is one of the India’s leading FMCG company with household brands in the healthcare and personal care space. The company has over four decades of experience and a series of successful brand launches. The innovative nature of our products have gained wide acceptance beyond national boundaries. Paras Pharmaceuticals is known for developing new categories and is widely respected for its category creation ability. As a result, the company has one super brand in pain management and we are market leaders in at least two other healthcare categories. As a corporate the company believes in providing innovative solutions to everyday health and personal care problems and has an entrepreneurial culture to build categories and brands.
Pfizer Limited is an India-based pharmaceutical company that has a portfolio of approximately 140 products across over 15 therapeutic areas. The company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The company offers a range of products for anti-allergic, anti-diabetic, antihistamine, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins among others. The company has its own manufacturing facility at Thane and Goa. It has various independent contract/ third party manufacturers based across the country. The company sells its products through independent distributors primarily in India. Pfizer has won the Golden Peacock Innovative Product for Magnex.
Panacea Biotec Limited
Panacea Biotec Limited is a health management company, set up in 1984, with a commitment to make novel and innovative medicines affordable to the masses a dream of healthy India, and got listed in 1995 as Panacea Biotec Ltd. The company’s principal business activity is the manufacture of allopathic pharmaceuticals preparations. Its segments include vaccines, formulations, research and development. The company’s product portfolio includes prescription products in therapeutic areas, such as oncology, and nephrology and transplant management. Panacea Biotec is the largest vaccine manufacturing company in India and is well acknowledged by the UN Health Agencies in partnering the Polio eradication initiative with supplies of millions of doses of WHO Pre-qualified Polio vaccine. Panacea Biotec is the first company in to have developed fully liquid Pentavalent vaccine.
Piramal Enterprises Limited
Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries forayed into the health care space in 1988.
Piramal Healthcare has its manufacturing bases across India, UK, Scotland, USA and Canada through subsidiaries. At present it is the third largest player in the global Inhalation Anesthesia (IA) market, and the only company in the world with a complete product portfolio of inhalation anesthetics drugs.
Piramal Healthcare have partnered with the largest and most reputed organizations in the global pharmaceuticals industry to expand our product offering and deliver the best innovations to our customers.
Piramal Healthcare is made up of the following seven key business divisions: Pharma solutions, critical care, consumer products, imaging and phyto-medicines.
Sanofi India Limited
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions since 1956. The company operates through three segments: pharmaceuticals, human vaccines (Vaccines) and animal health.Sanofi India Limited was incorporated under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited and Hoechst Marion Roussel Limited. The shares of Sanofi India Limited are quoted on the Bombay Stock Exchange and the National Stock Exchange. It also operates in the other segment, which includes the effects of retained commitments in respect of divested activities.
Shasun Pharmaceuticals Limited
Shasun Pharmaceuticals Limited is an integrated, leading global supplier of development and manufacturing services for intermediates, API (active pharmaceutical ingredients) and formulations to the pharmaceutical industry. Shasun Pharmaceuticals Limited (Formerly known as Shasun Chemicals and Drugs Ltd.) was incorporated in 1976 and is headquartered in Chennai. The company is a manufacturer and supplier of Ibuprofen and Ibuprofen derivatives. It offers a range of products in the areas of pain management, anti ulcerants and central nervous system (CNS). It offers services from the discovery stage to commercial manufacture and formulations. It offers technology services, which include chiral technologies and fluorination. It offers APIs for pain management and musculoskeletal, cardiovascular, anti-infective, gastrointestinal and cough suppressants, among others.
SeQuent Scientific Limited
SeQuent Scientific Limited is a holding company, whose segments include pharmaceuticals, specialty chemicals and analytical services. It focuses on products for livestock, poultry and companion animals.
It also offers laboratory and technical support services. On the human health front, the company serves the female healthcare with focus on steroids and hormones. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of animal health (API and formulation) and human health (API). The company is equipped to cater to the domestic and global demands with cutting-edge R&D, highly flexible manufacturing capabilities and a competitive supply-chain network.
Strides Shasun Limited
Strides Shasun Limited (Formerly Strides Arcolab Limited), incorporated in 1990, manufactures pharmaceutical dosage forms in branded as well generic categories. The dosages are manufactured in form of tablets, capsules, soft gelatin capsules, parenterals and semi–solids. The company manufactures soft gels and steriles. It has 13 manufacturing facilities located across the world –– in India, Singapore, Brazil, Mexico, Poland, Italy.These facilities have received approval from various regulatory authorities namely MHHRA, TGA, MCC, ANVISA. The company’s Bangalore plant is pre–qualified by WHO to manufacture of HIV/ AIDS and anti–TB drugs. The company is among the top 5 soft gelatin capsule manufacturers in world. It has partnered with major pharmaceutical companies located in Australia, South Africa, Europe, and USA. The company has a joint venture with Akorn –– Akorn–Strides, LLC –– to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets.
Shilpa Medicare Limited
Shilpa Medicare Limited was incorporated in 1987 at Raichur, Karnataka. The commercial production in the SML was started in November 1989. It is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The company’s segments include bulk drug/intermediates and energy. It deals with APIs, intermediates, formulations, new drug delivery systems, peptides/biotech products and specialty chemicals. Shilpa Medicare’s facilities have received key regulatory approvals for its facilities as well as for the products from EDQM, UK-MHRA, TGA, USFDA, PMDA and KFDA.
Suven Life Sciences
Suven Life Sciences was promoted by Venkat Jasti couple, in 1989, as a Private Limited Company. Later, it was converted into a public limited company in January 1995. Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets. The company has six internally discovered therapeutic drug candidates currently, in pre–clinical stage of development targeting conditions such as ADHD, dementia, depression, Huntington’s disease. Parkinson’s disease and obesity are in addition to developmental candidate SUVN–502 for Alzheimer’s disease and Schizophrenia. Shares are listed at BSE, NSE, and Hyderabad Stock Exchange (HSE). It has a state of the art R&D center recognized by Department of Scientific & Industrial Research (DSIR), Ministry of Science and Technology.
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited’s business segments include US business, Indian branded generics business, emerging markets, global consumer healthcare business and active pharmaceutical ingredients (API). Its rest of world segment includes western Europe, Canada, Australia, New Zealand and other markets. The company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. Its products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are in India, the United States and Brazil, among others. It acquired Ranbaxy in 2014 and this makes Sun pharma the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest speciality generic company globally.
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments. It offers products in various categories, including tablets, capsule and parenteral. Its geographical segments include India and abroad.
It has three world-class manufacturing facilities at Indrad (Gujarat), Baddi (Himachal Pradesh) and Sikkim. The facilities are approved by USFDA, WHO, MHRA, TGA and other global regulatory bodies. Torrent Pharma is the sole manufacturer of Insulin Formulations for Novo Nordisk in India since the early ‘90s and has also set up a dedicated formulation and packaging facility for Insulin.
Recently, Torrent Pharma acquired the branded domestic formulations business of Elder Pharmaceuticals in India and Nepal. Torrent Pharma has a strong international presence spanning over 40 countries with over 1200 product registrations.
Unichem Laboratories Limited
Unichem Laboratories Limited manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has various pharma products for addressing therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management. Its brands include Losar, TG Tor, Olsar, Tolol and Trika. Promoted by a pioneer of the Indian pharmaceuticals business, Amrut Mody, Unichem Laboratories has grown to become one of India’s most respected pharmaceutical companies. It is committed to delivering better health through superior products. By combining strategic research and in-depth industry knowledge, Unichem aims to transform itself into a global pharmaceutical drug company with an increasing focus on cutting-edge research and developed markets.
Wockhardt Limited is a pharmaceutical and biotechnology company. Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research- based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. The company’s businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. It has approximately three research centers globally. Wockhardt is a true Indian multi-national company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has three research centres and 12 manufacturing plants.
USV Limited is a 55 year old leading healthcare company thatbegan as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. The company’s products includes active pharmaceutical ingredients (APIs), fixed dosages formulations (FDF), peptides, biosimilars and injectables. These are manufactured in the company’s CGMP compliant plants in India. USV Limited markets its products globally to 75 countries. In India, the company is recognised for its leadership in the oral anti-diabetic market. USV has a significant presence in the areas of vitamins, minerals, nutrients, dermatology, gastroenterology and CNS.
Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. Zydus Cadila, with a core competence in the field of healthcare provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products. The group has launched Exemptia, the world’s first biosimilar for adalimumab, the largest selling therapy worldwide for inflammatory arthritis. Zydus is also the only Indian pharma company to launch its own patented NCE – Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.
The group was incorporated in 1952 by Late Mr. Ramanbhai B. Patel, a first-generation entrepreneur and one of the stalwarts of the Indian pharmaceutical industry. In 1995, the group restructured its operations and Cadila Healthcare came into being under the aegis of the Zydus group. Zydus Cadila, today, is spearheaded by Pankaj R. Patel, the Chairman and Managing Director of the group.